Bicycle Therapeutics Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | |
| – | +23.3% | +114.5% | +34.8% | +33.0% | +10.3% | +161.8% | +77.4% | +9.6% | -10.5% | |
| – | +318.7% | +98.6% | +201.4% | +111.3% | +85.5% | +121.6% | +21.3% | +17.3% | +3.6% | |
| – | +415.4% | +166.2% | +401.4% | -22.1% | +90.4% | +77.2% | – | – | – | |
| – | +603.8% | -150.9% | – | – | +50.1% | -98.2% | +11,308.2% | -143.6% | – | |
| – | +357.4% | +6.6% | +31.1% | -22.8% | +69.2% | +835.3% | -84.6% | -57.8% | +90.7% | |
| – | +357.4% | +6.6% | +31.1% | -22.8% | +69.2% | +835.3% | -84.6% | -57.8% | +90.3% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +244.2% | -101.0% | – | – | – | – | – | – | – | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | -99.5% | |
| – | +245.1% | -56.1% | +129.8% | +7.5% | +410.4% | -97.9% | +3,636.2% | +107.9% | -100.0% | |
| – | +1,586.2% | -107.4% | – | +52.7% | +589.9% | -132.9% | – | +88.0% | -171.2% | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.